KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021)

Historic Amortization - Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 3 years, with Q4 2021 value amounting to $1.2 million.

  • Aurinia Pharmaceuticals' Amortization - Intangibles changed N/A to $1.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2021, which is 6153.85% up from last year.
  • Aurinia Pharmaceuticals' Amortization - Intangibles amounted to $1.2 million in Q4 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' Amortization - Intangibles peaked at $1.2 million during Q4 2021, and registered a low of $300000.0 during Q1 2020.